Burtonsville MD September 19, 2022

We are excited to share that ChiRhoClin.com was redesigned to focus on how we can assist a variety of medical groups. Its new user interface is intuitive and responsive for a variety of solutions to pancreatic issues. ChiRhoClin is rebranding itself as the orphan theranostic company. Our goal is to develop or acquire products that will have both Therapeutic and Diagnostic benefits for patients.

CEO Skip Purich stated, “We spent the last year focused on rebranding ChiRhoClin and optimizing our key competencies into a unifying message. ChiRhoClin has been in this emerging area of combining therapeutics and diagnostics uses for some time, but have not articulated it until now. By embracing new search engine optimization for ChiRhoClin’s new website and focusing on the core areas where we can help facilitate collaboration in the gastrointestinal, radiological, pediatrics, and pancreatic community, ChiRhoClin will focus its drug development in the theranostic area.”

Please visit our new website to learn how ChiRhoClin and our products could assist in your practice. ChiRhoClin is a resource and reference for everything associated with pancreatic function and dysfunction.  We are excited to offer solutions to your GI and pancreatic medical problems.

ChiRhoClin would like to recognize and thank emagineHealth for designing a fantastic website.  They are a professional web design and marketing company.  The emagineHealth team took the time to understand our current message and refocus our brand for the next generation of fellows, doctors, and members of the medical community. They coordinated the rebranding and built a user friendly, optimal, detail-oriented website that can be updated effortlessly and provide a streamlined message. We appreciate the commitment emagineHealth put in over this past year and we look forward to continuing our business relationship.

About ChiRhoClin, Inc.

ChiRhoClin, Inc., a Maryland based family run corporation founded in 1991.  Our mission is to develop orphan theranostic drug products for the Gastrointestinal, Pediatric, and Radiological community that will diagnose and/or treat pancreatic and gastrointestinal diseases. We aim to create a culture of scientific exchange, emphasizing research in acute and chronic pancreatitis, pancreatic cancer, gastrointestinal imaging, and genetic testing.  We continue to donate time, energy, and resources to encourage pancreatic research though our pancreatic grant program.


emagineHealth is the Digital-First Agency for Healthcare and Life Sciences.

We’re a team of 50+ individuals located across the U.S.  with a passion for health. Our clients are saving, extending and improving lives – and we’re connecting them to the patients, caregivers and healthcare professionals who need them. With 25+ years of experience working with 2,000+ brands, we’re one of the most experienced teams in Digital-First marketing for the healthcare and life sciences sectors.

We deliver the critical messages and content that promote a healthier world.

With a Digital-First approach, we develop brands and attract audiences through strategic content, websites, SEO, digital advertising and offline media. Our unmatched (in-house) digital experience allows us to pull off client initiatives that traditional agencies and P.R. firms shy away from. At emagineHealth, we embrace challenging projects, timelines, and objectives.

Our team is driven by the innovation and compassion our clients demonstrate – whether through the development of life-saving drugs and devices, or by the leading-edge care they provide for patients to make them healthy.

For more information, please visit www.emaginehealth.com or call 877-530-7993.

e-mail: info@emagine.com.

Media Contact:

If you would like more information on ChiRhoClin, Inc. or our new CEO, please visit www.ChiRhoClin.com, call 1-877-272-4888 or Email chirhoclin@chirhoclin.com.